M. Addis, M. Loi, C. Lepiani, M. Cau, and M. Melis, OCRLMutation analysis in Italian patients with Lowe syndrome, Human Mutation, vol.23, issue.5, pp.524-525, 2004.
DOI : 10.1002/humu.9239

M. Addis, C. Meloni, R. Congiu, S. Santaniello, F. Emma et al., A novel interstitial deletion in Xq25, identified by array-CGH in a patient with Lowe syndrome, European Journal of Medical Genetics, vol.50, issue.1, pp.79-84, 2007.
DOI : 10.1016/j.ejmg.2006.10.003

O. Attree, I. Olivos, I. Okabe, C. Bailey, D. Nelson et al., The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase, Nature, vol.358, issue.6383, pp.239-242, 1992.
DOI : 10.1038/358239a0

A. Bökenkamp, D. Böckenhauer, H. Cheong, B. Hoppe, V. Tasic et al., Dent-2 Disease: A Mild Variant of Lowe Syndrome, The Journal of Pediatrics, vol.155, issue.1, pp.94-99, 2009.
DOI : 10.1016/j.jpeds.2009.01.049

D. Böckenhauer, A. Bokenkamp, W. Van-'t-hoff, E. Levchenko, J. Kist-van-holte et al., Renal Phenotype in Lowe Syndrome: A Selective Proximal Tubular Dysfunction, Clinical Journal of the American Society of Nephrology, vol.3, issue.5, pp.1430-1436, 2008.
DOI : 10.2215/CJN.00520108

L. Chabaa, N. Monnier, S. Dahri, M. Jorio, J. Lunardi et al., Oculocerebro-renal Lowe syndrome: clinical, biochemical and molecular studies in a Moroccan patient, Ann Biol Clin, vol.64, pp.53-59, 2006.

Y. Chou, S. Chao, Y. Chiou, and S. Lin, Identification of OCRL1 mutations in two Taiwanese Lowe syndrome patients, Acta Paediatr Taiwan, vol.46, pp.226-229, 2005.

R. Choudury, A. Diao, F. Zhang, E. Eisenberg, A. Saint-pol et al., Lowe Syndrome Protein OCRL1 Interacts with Clathrin and Regulates Protein Trafficking between Endosomes and the Trans-Golgi Network, Molecular Biology of the Cell, vol.16, issue.8, pp.3467-3479, 2005.
DOI : 10.1091/mbc.E05-02-0120

C. Coutton, N. Monnier, J. Rendu, and J. Lunardi, Development of a multiplex ligation-dependent probe amplification (MLPA) assay for quantification of the OCRL1 gene, Clinical Biochemistry, vol.43, issue.6, pp.609-614, 2010.
DOI : 10.1016/j.clinbiochem.2009.12.012

URL : https://hal.archives-ouvertes.fr/inserm-00497653

C. Dent and M. Friedman, Hypercalcuric Rickets Associated with Renal Tubular Damage, Archives of Disease in Childhood, vol.39, issue.205, pp.240-249, 1964.
DOI : 10.1136/adc.39.205.240

O. Dewuyst, P. Christie, P. Courtoy, R. Beauwens, and R. Thakker, Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease, Human Molecular Genetics, vol.8, issue.2, pp.247-257, 1999.
DOI : 10.1093/hmg/8.2.247

M. Dressman, I. Olivos-glander, R. Nussbaum, and S. Suchy, -Golgi Network of Fibroblasts and Epithelial Cells, Journal of Histochemistry & Cytochemistry, vol.92, issue.2, pp.179-190, 2000.
DOI : 10.1177/002215540004800203

URL : https://hal.archives-ouvertes.fr/hal-00796618

K. Erdmann, Y. Mao, H. Mccrea, R. Zoncu, S. Lee et al., A Role of the Lowe Syndrome Protein OCRL in Early Steps of the Endocytic Pathway, Developmental Cell, vol.13, issue.3, pp.377-390, 2007.
DOI : 10.1016/j.devcel.2007.08.004

A. Faucherre, P. Desbois, F. Nagao, V. Satre, J. Lunardi et al., Lowe syndrome protein Ocrl1 is translocated to membrane ruffles upon Rac GTPase activation: a new perspective on Lowe syndrome pathophysiology, Human Molecular Genetics, vol.14, issue.11, pp.1441-1448, 2005.
DOI : 10.1093/hmg/ddi153

URL : https://hal.archives-ouvertes.fr/inserm-00388677

A. Faucherre, P. Desbois, V. Satre, J. Lunardi, O. Dorseuil et al., Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network, Human Molecular Genetics, vol.12, issue.19, pp.2449-2456, 2003.
DOI : 10.1093/hmg/ddg250

A. Gropman, S. Levin, L. Yao, S. Suchy, S. Sabnis et al., Unusual renal features of Lowe syndrome in a mildly affected boy, American Journal of Medical Genetics, vol.92, issue.5, pp.461-466, 2000.
DOI : 10.1002/1096-8628(20001218)95:5<461::AID-AJMG10>3.0.CO;2-D

H. Jr, R. Raja, K. Koich, A. Huebber, P. Reid et al., Evidence for genetic heterogeneity in Dent disease, Kidney Int, vol.65, pp.1615-1620, 2004.

H. Jr, R. Shrimpton, A. Knohl, S. Hueber, P. Hoppe et al., Dent Disease with mutations in OCRL1, Am J Hum Genet, vol.76, pp.260-267, 2005.

N. Hyvola, A. Diao, E. Mckenzie, A. Skippen, S. Cockcroft et al., Membrane targeting and activation of the Lowe syndrome protein OCRL1 by rab GTPases, The EMBO Journal, vol.13, issue.16, pp.3750-3761, 2006.
DOI : 10.1074/jbc.273.3.1574

T. Kawano, Y. Indo, H. Nakazato, M. Shimadzu, and I. Matsuda, Oculocerebrorenal syndrome of Lowe: Three mutations in the OCRL1 gene derived from three patients with different phenotypes, American Journal of Medical Genetics, vol.77, issue.5, pp.348-355, 1998.
DOI : 10.1002/(SICI)1096-8628(19980605)77:5<348::AID-AJMG2>3.3.CO;2-H

C. Keilhauer, A. Gal, J. Sold, J. Zimmermann, K. Netzer et al., Klinische Befunde eines Patienten mit Lowe-Syndrom und einer Splice Site Mutation im OCRL1-Gen, Klinische Monatsbl??tter f??r Augenheilkunde, vol.224, issue.3, pp.207-209, 2007.
DOI : 10.1055/s-2007-962947

T. Kubota, A. Sakurai, K. Arakawa, M. Shimazu, K. Wakui et al., Identification of two novel mutations in the OCRLI gene in Japanese families with Lowe syndrome, Clinical Genetics, vol.379, issue.3, pp.199-202, 1998.
DOI : 10.1111/j.1399-0004.1998.tb04284.x

A. Leahey, L. Charnas, and R. Nussbaum, gene in patients with the oculocerebrorenal syndrome of Lowe, Human Molecular Genetics, vol.2, issue.4, pp.461-463, 1993.
DOI : 10.1093/hmg/2.4.461

U. Lichter-konecki, L. Farber, J. Cronin, S. Suchy, and R. Nussbaum, The effect of missense mutations in the RhoGAP-homology domain on ocrl1 function, Molecular Genetics and Metabolism, vol.89, issue.1-2, pp.121-128, 2006.
DOI : 10.1016/j.ymgme.2006.04.005

T. Lin, B. Orrison, A. Leahey, S. Suchy, D. Bernard et al., Spectrum of Mutations in the OCRL1Gene in the Lowe Oculocerebrorenal Syndrome, The American Journal of Human Genetics, vol.60, issue.6, pp.1384-1388, 1997.
DOI : 10.1086/515471

T. Lin, B. Orrison, S. Suchy, R. Lewis, and R. Nussbaum, Mutations Are Not Uniformly Distributed throughout theOCRL1Gene in Lowe Syndrome Patients, Molecular Genetics and Metabolism, vol.64, issue.1, pp.58-61, 1998.
DOI : 10.1006/mgme.1998.2687

S. Lloyd, S. Pearce, S. Fischer, K. Steinmeyer, B. Schwappach et al., A common molecular basis for three inherited kidney stone diseases, Nature, vol.379, issue.6564, pp.445-449, 1996.
DOI : 10.1038/379445a0

M. Loi, Lowe syndrome, Orphanet Journal of Rare Diseases, vol.1, issue.1, pp.16-21, 2006.
DOI : 10.1186/1750-1172-1-16

C. Lowe, M. Terrey, and E. Maclachan, Organic aciduria, decreased renal ammonia production, hydrophtalmos, and mental retardation: a clinical entity, Am J Dis Child, vol.83, pp.164-184, 1952.

M. Lowe, Structure and Function of the Lowe Syndrome Protein OCRL1, Traffic, vol.99, issue.Pt 3, pp.711-719, 2005.
DOI : 10.1111/j.1600-0854.2005.00311.x

/. Mazo, Y. Balkin, D. Zoncu, R. Erdmann, K. Tomasini et al., A PH domain within OCRL bridges clathrinmediated membrane trafficking to phosphoinositide metabolism, EMBO J, vol.28, pp.1831-1842, 2009.

H. Mccrea, S. Paradise, L. Tomasini, M. Addis, M. Melis et al., All known patient mutations in the ASH-RhoGAP domains of OCRL affect targeting and APPL1 binding, Biochemical and Biophysical Research Communications, vol.369, issue.2, pp.493-499, 2008.
DOI : 10.1016/j.bbrc.2008.02.067

N. Monnier, V. Satre, E. Lerouge, F. Berthoin, and J. Lunardi, OCRL1 mutation analysis in French Lowe syndrome patients: Implications for molecular diagnosis strategy and genetic counseling, Human Mutation, vol.16, issue.2, pp.157-165, 2000.
DOI : 10.1002/1098-1004(200008)16:2<157::AID-HUMU8>3.0.CO;2-9

R. Nussbaum, M. Orrison, P. Jänne, L. Charnas, and A. Chinault, Physical mapping and genomic structure of the Lowe syndrome gene OCRL1, Human Genetics, vol.99, issue.2, pp.145-150, 1997.
DOI : 10.1007/s004390050329

I. Olivos-glander, P. Jänne, and R. Nussbaum, The oculocerebral syndrome gene product is a 105-kD protein localized to the Golgi complex, Am J Hum Genet, vol.57, pp.817-823, 1995.

J. Peck, G. Douglas, C. Wu, and P. Burbelo, Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships, FEBS Letters, vol.130, issue.1-3, pp.239-242, 2002.
DOI : 10.1016/S0014-5793(02)03331-8

J. Peverall, E. Edkins, J. Goldblatt, and A. Murch, Identification of a novel deletion of the entire OCRL1 gene detected by FISH analysis in a family with Lowe syndrome, Clinical Genetics, vol.57, issue.9, pp.479-482, 2000.
DOI : 10.1034/j.1399-0004.2000.580609.x

N. Piwon, W. Günther, and M. Schwake, ClC-5 Cl À -channel disruption impairs endocytosis in a mouse model for Dent disease, Nature, vol.408, pp.369-373, 2000.

W. Röschinger, A. Muntau, G. Rudolph, A. Roscher, and S. Kammerer, Carrier Assessment in Families with Lowe Oculocerebrorenal Syndrome: Novel Mutations in the OCRL1 Gene and Correlation of Direct DNA Diagnosis with Ocular Examination, Molecular Genetics and Metabolism, vol.69, issue.3, pp.213-222, 2000.
DOI : 10.1006/mgme.1999.2955

V. Satre, N. Monnier, F. Berthoin, C. Ayuso, A. Joannard et al., Characterization of a Germline Mosaicism in Families with Lowe Syndrome, and Identification of Seven Novel Mutations in the OCRL1 Gene, The American Journal of Human Genetics, vol.65, issue.1, pp.68-76, 1999.
DOI : 10.1086/302443

J. Schneider, E. Boltshauser, T. Neuhaus, C. Rauscher, and E. Martin, MRI and Proton Spectroscopy in Lowe Syndrome, Neuropediatrics, vol.32, issue.1, pp.45-48, 2001.
DOI : 10.1055/s-2001-12221

M. Schröder and R. Kaufman, THE MAMMALIAN UNFOLDED PROTEIN RESPONSE, Annual Review of Biochemistry, vol.74, issue.1, pp.739-789, 2005.
DOI : 10.1146/annurev.biochem.73.011303.074134

S. Sehti, A. Bagga, A. Gulati, P. Hari, N. Gupta et al., Mutations in OCRL1 gene in Indian children with Lowe syndrome, Clin Exp Nephrol, vol.12, pp.358-362, 2008.

T. Sekine, K. Nozu, R. Iyengar, J. Fu, X. Matsuo et al., OCRL1 mutations in patients with Dent disease phenotype in Japan, OCRL1 mutations in patients with Dent disease phenotype in Japan, pp.975-980, 2007.
DOI : 10.1007/s00467-007-0454-x

A. Shrimpton, H. Jr, R. Knohl, S. Hueber, P. Reed et al., <i>OCRL1</i> Mutations in Dent 2 Patients Suggest a Mechanism for Phenotypic Variability, Nephron Physiology, vol.112, issue.2, pp.27-36, 2009.
DOI : 10.1159/000213506

S. Suchy, I. Olivos-glander, and R. Nussbaum, Lowe syndrome, a deficiency of a phosphatidylinositol 4,5-bis-inositol-4,5-biphosphate 5-phosphatase, Hum Mol Biol, vol.4, pp.2245-2250, 1995.

S. Suchy and R. Nussbaum, The Deficiency of PIP2 5-Phosphatase in Lowe Syndrome Affects Actin Polymerization, The American Journal of Human Genetics, vol.71, issue.6, pp.1420-1427, 2002.
DOI : 10.1086/344517

L. Swan, L. Romasini, M. Pirrucello, J. Lunardi, D. Camilli et al., Two closely related endocytic proteins that share a common OCRL-binding motif with APPL1, Proceedings of the National Academy of Sciences, vol.107, issue.8, pp.3511-3516, 2010.
DOI : 10.1073/pnas.0914658107

URL : https://hal.archives-ouvertes.fr/inserm-00498649

R. Thakker, Pathogenesis of Dent's disease and related syndromes of X-linked nephrolithiasis, Kidney International, vol.57, issue.3, pp.787-793, 2000.
DOI : 10.1046/j.1523-1755.2000.00916.x

E. Tosetto, M. Addis, G. Caridi, C. Meloni, F. Emma et al., Locus heterogeneity of Dent???s disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations, Pediatric Nephrology, vol.32, issue.942, pp.1967-1973, 2009.
DOI : 10.1007/s00467-009-1228-4

Y. Tsujishita, S. Guo, L. Stolz, J. York, and J. Hurley, Specificity Determinants in Phosphoinositide Dephosphorylation, Cell, vol.105, issue.3, pp.379-389, 2001.
DOI : 10.1016/S0092-8674(01)00326-9

A. Ungewickell, M. Waed, E. Ungewickell, and P. Majerus, The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin, Proceedings of the National Academy of Sciences, vol.101, issue.37, pp.13501-13506, 2004.
DOI : 10.1073/pnas.0405664101

B. Utsch, A. Bökenkamp, M. Benz, N. Besbas, J. Dötsch et al., Novel OCRL1 Mutations in Patients With the Phenotype of Dent Disease, American Journal of Kidney Diseases, vol.48, issue.6, pp.942-954, 2006.
DOI : 10.1053/j.ajkd.2006.08.018

J. Whisstock, S. Romerao, R. Gurung, H. Nandurkar, L. Ooms et al., The Inositol Polyphosphate 5-Phosphatases and the Apurinic/Apyrimidinic Base Excision Repair Endonucleases Share a Common Mechanism for Catalysis, Journal of Biological Chemistry, vol.275, issue.47, pp.37055-37061, 2001.
DOI : 10.1074/jbc.M006244200

X. Zhang, A. Jefferson, V. Avethavekiat, and P. Majerus, The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase., Proceedings of the National Academy of Sciences, vol.92, issue.11, pp.4853-4856, 1995.
DOI : 10.1073/pnas.92.11.4853